CristinaGaleArriensMDMSCS

Clinical Trials

• Pilot Study - Effect of Omega-3 on Systemic Lupus Erythematosus Start of enrollment: 2012 Jan 01

  Completed

  Phase 2

• Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis Start of enrollment: 2014 Mar 14

  Completed

  Phase 4

• Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches Start of enrollment: 2014 Jan 01

  Completed

  Phase 2

• Evaluation of Belimumab Impact on a BLyS Activity Signature Test in the Absence of Confounding Polypharmacy Start of enrollment: 2014 Oct 01

  Unknown status

  Phase 4

• Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus Start of enrollment: 2015 Jun 09

  Completed

  Phase 3

• Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis Start of enrollment: 2015 Nov 04

  Completed

  Phase 2

• Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis Start of enrollment: 2016 Apr 27

  Terminated

  Phase 2

• Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus Start of enrollment: 2016 Jun 30

  Completed

  Phase 3

• Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis Start of enrollment: 2016 Sep 01

  Completed

  Phase 4

• Aurinia Renal Response in Active Lupus With Voclosporin Start of enrollment: 2017 May 17

  Completed

  Phase 3

• Study of Anti-Malarials in Incomplete Lupus Erythematosus Start of enrollment: 2017 Dec 28

  Active, not recruiting

  Phase 2

• An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus Start of enrollment: 2017 Sep 21

  Completed

  Phase 2

• MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLE Start of enrollment: 2017 Apr 10

  Terminated

  Phase 2

• Aurinia Renal Assessments 2: Aurinia Renal Response in Lupus With Voclosporin Start of enrollment: 2019 Sep 29

  Completed

  Phase 3

• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II) Start of enrollment: 2018 Aug 02

  Completed

  Phase 3

• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) Start of enrollment: 2019 Sep 09

  Terminated

  Phase 3

• A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis Start of enrollment: 2019 Apr 25

  Active, not recruiting

  Phase 4

• Long-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus Erythematosus Start of enrollment: 2019 Mar 26

  Active, not recruiting

  Phase 2

• An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis Start of enrollment: 2019 Jul 15

  Terminated

  Phase 2

• Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Start of enrollment: 2019 May 16

  Completed

  Phase 3

• Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors Start of enrollment: 2019 Oct 31

  Completed

  Phase 3

• A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE) Start of enrollment: 2020 Aug 19

  Completed

  Phase 2

• Join now to see all